1-20 of 116
Hun Ju Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Advanced-Stage Classical Hodgkin Lymphoma

Clinical Trials & Observations
Hun Ju Lee, Rod Ramchandren, Judah Friedman, Jason M. Melear, Ian W. Flinn, John M. Burke, Yuliya Linhares, Paul Alan Gonzales, Matthew Peterson, Mihir Raval, Rangaswamy Chintapatla, Tatyana A. Feldman, Habte A. Yimer, Miguel Islas-Ohlmayer, Ameet Patel, Leland Metheny, Asad Dean, Vishal Rana, Mitul D. Gandhi, John S Renshaw, Linda Ho, Michelle A. Fanale, Wenchuan Guo, Christopher A. Yasenchak
Journal: Blood
Blood blood.2024024681.
https://doi.org/10.1182/blood.2024024681
Published: 2024
Includes: Supplemental data
Journal Articles

Brentuximab Associated Guillain-Barré Syndrome (BV-GBS): Case Series and a Review of Pharmacovigilance FDA Adverse Reporting System (FAERS)

Roshini Pradeep, Zeynep Nazli Benekli, Ranjit Nair, Luis Malpica, Hun Ju Lee, Eguono Maples, Samantha Carlson, Luis E. Fayad, Sairah Ahmed, Swami P. Iyer
Journal: Blood
Blood (2024) 144 (Supplement 1): 7776.
https://doi.org/10.1182/blood-2024-202119
Published: 2024
Journal Articles

Acalabrutinib with Rituximab Is Highly Effective First Line Treatment for Older Patients with Mantle Cell Lymphoma

Preetesh Jain, Chi Young Ok, Jason R. Westin, Holly A Hill, Ranjit Nair, Swami P. Iyer, Ahmed Fetooh, Hun Ju Lee, Sairah Ahmed, Rashmi Kanagal-Shamanna, Fatima Z Jelloul, Luis Malpica, Yang Liu, Yijing Li, Lei Feng, Maria Badillo, Selvi Thirumurthi, Anita Deswal, Cezar Iliescu, Vinh Quang Nguyen, Anastasiia A. Bolshakova, Dmitry Tabakov, Michael G Goldberg, Andrey Tyshevich, Tatiana Vasileva, Daria Shavronskaya, Krystle Nomie, Guilin Tang, Keyur P. Patel, Francisco Vega, L. Jeffrey Medeiros, Christopher R. Flowers, Michael Wang
Journal: Blood
Blood (2024) 144 (Supplement 1): 3038.
https://doi.org/10.1182/blood-2024-206042
Published: 2024
Journal Articles

CTEP 10590, NORM: Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase II Trial with Either Rituximab or Mosunetuzumab

Raphael Steiner, Allison M. Bock, Alex F. Herrera, Omer Zulfa, Marc Hoffmann, Sami Ibrahimi, Natalie Galanina, Hun Ju Lee, Michael Green, Ruitao Lin, Chelsea C. Pinnix, Alison Moskowitz, Joachim Yahalom, Dai Chihara
Journal: Blood
Blood (2024) 144 (Supplement 1): 4434.2.
https://doi.org/10.1182/blood-2024-202516
Published: 2024
Journal Articles

Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study

Hun Ju Lee, Gregory Ravizzini, Eslam Aboismail, Jenna Wixom, Jared Henderson, Luis E. Fayad, Sairah Ahmed, Ranjit Nair, Jason R. Westin, Swaminathan P Iyer, Chijioke Nze, Ajlan Al Zaki, Francisco Vega, Michael Wang, Christopher R. Flowers, Luis Malpica
Journal: Blood
Blood (2024) 144 (Supplement 1): 1674.3.
https://doi.org/10.1182/blood-2024-212005
Published: 2024
Journal Articles

PRIMAVERA: A Modular Phase I/II Study to Evaluate the Safety, Tolerability, and Efficacy of AZD3470, a Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor, in Participants with Relapsed/Refractory Hematologic Malignancies

Tae Min Kim, Katharine L. Lewis, Juan Pablo Alderuccio, Hun Ju Lee, Enrico Derenzini, Pier Luigi Zinzani, Marco Ladetto, Elizabeth H. Phillips, Hervé Ghesquieres, François Lemonnier, Franck Morschhauser, Ana Sureda Balari, Antonia Rodriguez Izquierdo, Peter Borchmann, Matthew Weinstock, Jakub Svoboda, Emma Dean, Jelena Urosevic, Stefanie Meyer, Robert Chen, Richard Olsson, Kaitlyn Beyfuss, Graham P. Collins
Journal: Blood
Blood (2024) 144 (Supplement 1): 1674.2.
https://doi.org/10.1182/blood-2024-203060
Published: 2024
Journal Articles

Open-Label Phase 1 Study to Evaluate the Safety of SGN-35T in Patients with Relapsed/Refractory CD30-Expressing Lymphoid Malignancies (SGN35T-001; trial in progress)

Tatyana Feldman, Hun Ju Lee, Gizelle Popradi, Graham P. Collins, Daniel Morillo, Ming Jin Yan, Tara Chen, Youn H. Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 6356.
https://doi.org/10.1182/blood-2024-200265
Published: 2024
Journal Articles

T-Cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis Has Worse Survival When Compared to T-Cell Lymphoma: A Retrospective Analysis from a Single Tertiary Center

Amrit S. Gonugunta, Rishab Prakash, Ranjit Nair, Ajlan Al Zaki, Sairah Ahmed, Chijioke Nze, Dai Chihara, Frederick Hagemeister, Hun Ju Lee, Jason R. Westin, Krina K. Patel, Luis E. Fayad, Luis Malpica, Maria Alma Rodriguez, Michael Wang, Preetesh Jain, Paolo Strati, Sattva S. Neelapu, Christopher R. Flowers, Swaminathan P Iyer
Journal: Blood
Blood (2024) 144 (Supplement 1): 6420.
https://doi.org/10.1182/blood-2024-211482
Published: 2024
Journal Articles

Risk Analysis of Cytokine Release Syndrome, Immune Effector Cell- Associated Neurotoxicity Syndrome, and Immune Effector Cell- Associated Hemophagocytic Lymphohistiocytosis-like Syndrome in BiTE Therapy Vs CAR-T Therapy Using Real World Data

Alexandra Elias, Rishab Prakash, Ranjit Nair, Luis Malpica, Hun Ju Lee, Eguono Maples, Samantha Carlson, Luis E. Fayad, Krina K. Patel, Sairah Ahmed, Swaminathan P Iyer
Journal: Blood
Blood (2024) 144 (Supplement 1): 611.
https://doi.org/10.1182/blood-2024-212332
Published: 2024
Journal Articles

Updated Analysis of Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Nonbulky, Early-Stage Classical Hodgkin Lymphoma

Jeremy S. Abramson, David J. Straus, Nancy L. Bartlett, John M. Burke, Ryan C. Lynch, Eva Domingo Domenech, Brian Hess, Steven Schuster, Yuliya Linhares, Rod Ramchandren, Mitul Gandhi, Harsh R. Shah, Wojciech Jurczak, Alessandro Re, Uwe Hahn, H. Miles Prince, Wenchuan Guo, Griffith Davis, Linda Ho, Christopher Yasenchak, Hun Ju Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 460.
https://doi.org/10.1182/blood-2024-200992
Published: 2024
Journal Articles

A Randomized Phase 2 Study Incorporating Nivolumab and Brentuximab Vedotin into Radiation-Free Treatment of Early Stage Classic Hodgkin Lymphoma

Ann S. LaCasce, Deepa Jagadeesh, Hun Ju Lee, Lu Chen, David A. Bond, Matthew Weinstock, Matthew Mei, Tatyana Feldman, Allison M. Winter, Jeffrey A. Barnes, Amitkumar N. Mehta, Gaurav Goyal, Sairah Ahmed, Lisa Giulino Roth, Azra Borogovac, Kristie A. Blum, Jane N Winter, Mehdi Hamadani, Sonali M. Smith, Philippe Armand, Ian W. Flinn, Jeremy S. Abramson, Alex F. Herrera
Journal: Blood
Blood (2024) 144 (Supplement 1): 459.
https://doi.org/10.1182/blood-2024-204113
Published: 2024
Journal Articles

PET-Directed Therapy with ABVD Vs. Bv+AVD Followed By Nivolumab in Patients with Early Stage Hodgkin Lymphoma: A Propensity Score Matched Analysis of CALGB50604 and ACCRULY1601

Steven I. Park, Stephen M. Ansell, Danielle Boselli, Sharmila Giri, Jakub Svoboda, Stephen D Smith, Tatyana Feldman, L. Elizabeth Budde, Andrew J Ness, Philip Bierman, Hun Ju Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 458.
https://doi.org/10.1182/blood-2024-202207
Published: 2024
Journal Articles

Brentuximab Vedotin (BV) and Nivolumab (nivo) for Untreated Patients with Hodgkin Lymphoma (HL): Long-Term Results

Bruce D. Cheson, Nancy L. Bartlett, Betsy R. LaPlant, Hun Ju Lee, Ranjana H. Advani, Beth Christian, Catherine S. Diefenbach, Tatyana Feldman, Stephen M. Ansell
Journal: Blood
Blood (2024) 144 (Supplement 1): 3045.
https://doi.org/10.1182/blood-2024-207424
Published: 2024
Journal Articles

Peripheral Blood CAR T-Cell Level Using a Clia-Validated Assay Is Prognostic for Treatment Response and Icans in Large B-Cell Lymphoma

Anath Lionel, Naishu Kui, Ryan Sun, Eslam Aboismail, Sanjit Om Tewari, Ajlan Al Zaki, Sushanth Gouni, Preetesh Jain, Dai Chihara, Swaminathan P Iyer, Michael Wang, Ranjit Nair, Luis Enrique Malpica Castillo, Hun Ju Lee, Chijioke Nze, Luis E. Fayad, Frederick Hagemeister, Maria Alma Rodriguez, Amy A. Ayers, Cristina Gutierrez, Gabriela Rondon, Fareed Khawaja, Partow Kebriaei, Elizabeth J. Shpall, Christopher R. Flowers, Jason R. Westin, Paolo Strati, Wei WANG, Sa A. Wang, Sairah Ahmed, Sattva S. Neelapu
Journal: Blood
Blood (2024) 144 (Supplement 1): 3001.
https://doi.org/10.1182/blood-2024-208300
Published: 2024
Journal Articles

Six Years Follow up of Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hyper CVAD/MTX in Patients (age ≤ 65 years) with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-1 Clinical Trial

Preetesh Jain, Hun Ju Lee, Jason Westin, Loretta J. Nastoupil, Luis Fayad, Ranjit Nair, Swami P. Iyer, Rashmi Kanagal-Shamanna, Ahmed Fetooh, Holly A Hill, Chi Young Ok, Wendy Chen, Onyeka Oriabure, Lei Feng, Guilin Tang, Francisco Vega, Maria Badillo, Christopher R. Flowers, Michael L. Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1688.
https://doi.org/10.1182/blood-2023-181312
Published: 2023
Journal Articles

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Advanced Stage Classical Hodgkin Lymphoma: Efficacy and Safety Results from the Single Arm Phase 2 Study

Hun Ju Lee, Ian W. Flinn, Jason Melear, Rod Ramchandren, Judah Friedman, John M. Burke, Yuliya Linhares, Paul Alan Gonzales, Mihir Raval, Rangaswamy Chintapatla, Tatyana Feldman, Habte A. Yimer, Miguel Islas-Ohlmayer, Asad Dean, Vishal Rana, Mitul Gandhi, John Scott Renshaw, Linda Ho, Michelle A. Fanale, Wenchuan Guo, Chris Yasenchak
Journal: Blood
Blood (2023) 142 (Supplement 1): 608.
https://doi.org/10.1182/blood-2023-173972
Published: 2023
Journal Articles

Acalabrutinib with Rituximab As First-Line Therapy for Older Patients with Mantle Cell Lymphoma - a Phase II Clinical Trial

Preetesh Jain, Chi Young OK, Loretta J. Nastoupil, Jason Westin, Holly A Hill, Ranjit Nair, Swami P. Iyer, Ahmed Fetooh, Hun Ju Lee, Sairah Ahmed, Rashmi Kanagal-Shamanna, Fatima Z Jelloul, Luis Enrique Malpica Castillo, Yang Liu, Yijing Li, Jovanny Vargas, Lei Feng, Maria Badillo, Selvi Thirumurthi, Guofan Xu, Anita Deswal, Cezar Iliescu, Vinh Quang Nguyen, Guilin Tang, Keyur P. Patel, Francisco Vega, L. Jeffrey Medeiros, Michael L. Wang, Christopher R. Flowers
Journal: Blood
Blood (2023) 142 (Supplement 1): 3036.
https://doi.org/10.1182/blood-2023-181216
Published: 2023
Journal Articles

Phase II Trial of Ibrutinib in Previously Untreated High-Risk Smoldering Mantle Cell Lymphoma

Charles Gaulin, Preetesh Jain, Ranjit Nair, Swami P. Iyer, Hun Ju Lee, Luis Fayad, Lei Feng, Yang Liu, Holly A Hill, Yijing Li, Chi Young Ok, Rashmi Kanagal-Shamanna, Onyeka Oriabure, Wendy Chen, Asiya Siddiqui, Guofan Xu, Anita Deswal, Cezar Iliescu, Maria Badillo, Shaoying Li, Michelle Ky, Michelle Avellaneda, Guilin Tang, Francisco Vega, Christopher R. Flowers, Michael L. Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 3034.
https://doi.org/10.1182/blood-2023-187903
Published: 2023
Journal Articles

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Early-Stage Classical Hodgkin Lymphoma (SGN35-027 Part C)

Jeremy S. Abramson, David J. Straus, Nancy L. Bartlett, John M. Burke, Ryan C Lynch, Eva Domingo Domenech, Brian Hess, Steven R. Schuster, Yuliya Linhares, Rod Ramchandren, Mitul Gandhi, Rex Mowat, Harsh Shah, Wojciech Jurczak, Alessandro Re, Uwe Hahn, H. Miles Prince, Wenchuan Guo, Linda Ho, Rose C. Beck, Christopher A. Yasenchak, Hun Ju Lee
Journal: Blood
Blood (2023) 142 (Supplement 1): 611.
https://doi.org/10.1182/blood-2023-172574
Published: 2023
Journal Articles

Prognostic Significance of CD30 Expression and Response to Brentuximab Vedotin in Patients with Angioimmunoblastic T Cell Lymphoma

Alexandra Elias, Mario L. Marques-Piubelli, Ranjit Nair, Rishab Prakash, Sairah Ahmed, Luis Malpica, Hun Ju Lee, Jie Xu, Christopher R. Flowers, Sattva S. Neelapu, Francisco Vega, Roberto Miranda, Swami P. Iyer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1714.
https://doi.org/10.1182/blood-2023-187939
Published: 2023